US Corporate Board Director Changes SEC Filings — June 25, 2026

25-06-2026

Nano Nuclear Energy Inc. terminated Dr. Florent Heidet as Chief Technology Officer and Head of Reactor Development effective June 22, 2026, with the termination unanimously approved by the Board. CEO James Walker has been appointed as Interim Head of Reactor Development. No financial terms or severance details were disclosed.

• · Termination was effective June 22, 2026, and included termination of Dr. Heidet's employment agreement dated March 6, 2025 (except for survival provisions).
• · No arrangements or understandings exist between James Walker and any other person regarding his appointment as Interim Head of Reactor Development.
• · No family relationships or reportable transactions under Item 404(a) of Regulation S-K involving James Walker.

25-06-2026

Worthington Steel reported Q4 FY2026 net sales of $929.2M, up 12% YoY, driven by higher direct volumes including the Sitem Group acquisition. However, the company posted a net loss attributable to controlling interest of $48.7M, compared to net earnings of $55.7M in the prior-year quarter, due primarily to $94.5M in non-cash impairment charges in the Electrical Steel reporting unit and increased acquisition-related expenses. Adjusted EBIT fell to $54.0M from $70.1M, and adjusted EPS declined to $0.74 from $1.05. Meanwhile, the company completed its majority acquisition of Klöckner & Co SE, securing approximately 62% of shares, marking a significant strategic milestone.

• · The company declared a quarterly dividend of $0.16 per share, payable on September 29, 2026 to shareholders of record Sept 15, 2026.
• · Direct tons sold increased 3% YoY, but legacy business (excluding Sitem Group) grew only 1%.
• · Toll processing sales declined 6% and toll volumes dropped 15% YoY due to the WSCP closure and softening mill customer demand.
• · Gross margin fell $8.9M (7%) driven by lower direct and toll spreads; direct spreads were impacted by a $20.8M inventory holding gain in Q4 FY2025 vs a $14.7M gain in Q4 FY2026.
• · SG&A expense increased $22.3M, primarily from $15.5M in professional fees related to the Kloeckner Acquisition.
• · Net cash provided by operating activities was $44.9M vs $53.9M in the prior year, a decrease of $9M (16.7%).
• · Investment in property, plant & equipment was $37.1M vs $45.5M in the prior year quarter.
• · The company ended Q4 FY2026 with $256.8M in debt and $84.6M in cash, resulting in net debt of $172.2M.
• · Full fiscal year 2026 net sales were $3,443.8M vs $3,093.3M in FY2025.
• · Full fiscal year 2026 adjusted EBIT was $160.8M vs $149.1M in FY2025.
• · Full fiscal year 2026 adjusted EPS was $2.23 vs $2.16 in FY2025 (slight increase).
• · The Kloeckner Acquisition closed on June 3, 2026, with Worthington Steel securing 62% of Kloeckner's outstanding shares at €11.00 per share.

25-06-2026

Insulet Corporation announced the appointment of Jonathan J. Mazelsky to its Board of Directors as an independent director, effective July 1, 2026. Mazelsky brings extensive leadership experience from IDEXX Laboratories, Philips Healthcare, and Agilent Technologies. The filing highlights his track record of driving growth and shareholder value, but no financial metrics or performance data are disclosed.

• · Mr. Mazelsky currently serves as Executive Chair of the board of directors of IDEXX Laboratories, Inc.
• · During his 14-year tenure at IDEXX, he served as President and CEO from October 2019 to May 2026.
• · Under Mazelsky's leadership as CEO, IDEXX revenues and stock price nearly doubled.
• · He holds an M.B.A. from the University of Chicago Booth School of Business and a B.A. in Mathematics from the University of Rochester.

25-06-2026

NeoGenomics appointed Carolyn Starrett to its Board of Directors, effective June 25, 2026. Ms. Starrett brings over 25 years of experience in data, technology, and AI in cancer care, having served as CEO of Flatiron Health from 2021 to 2025. The appointment is expected to enhance the company's strategic focus on AI and data insights in oncology diagnostics.

• · Ms. Starrett served as CEO and Board Director of Flatiron Health from April 2021 to September 2025.
• · She served as a Board Director at Foundation Medicine from 2021 to 2024.
• · She holds an MBA from Kellogg School of Management and a bachelor's degree from Brown University.

25-06-2026

Prairie Operating Co. appointed Gregory S. Patton as CEO and Michael Shelly as CFO on June 23, 2026. Patton, previously EVP and CFO, receives a base salary of $625,000 and an equity award of 850,000 shares (half performance-based, half time-based). Shelly, formerly a Managing Director at Citigroup, receives a base salary of $525,000 and an equity award of 1,400,000 shares (560,000 performance-based, 840,000 time-based). The Compensation Committee also amended 2025 PSU awards to set the initial stock value at $2.75 per share for total shareholder return calculations.

• · Patton's equity award consists of 425,000 performance-based RSUs (vesting on stock price milestones) and 425,000 time-based RSUs (vesting over three years).
• · Shelly's equity award consists of 560,000 performance-based RSUs (vesting on relative TSR vs. peer group) and 840,000 time-based RSUs (vesting ratably over three years).
• · The 2025 PSU awards were amended to set the initial stock value at $2.75 per share for TSR calculation; the performance period remains January 1, 2025 to December 31, 2027.
• · No family relationships or reportable transactions under Item 404(a) exist for either appointee.

25-06-2026

Dean Manson, Chief Legal Officer and Secretary of EchoStar Corporation and its subsidiary Hughes Satellite Systems Corporation, is resigning effective June 26, 2026, after 26 years with the company. Jeffrey Blum, Executive Vice President of Government Affairs, will serve as Acting Chief Legal Officer and Secretary while a permanent replacement is sought. The transition appears orderly with Manson staying on as Senior Advisor for a period.

• · Dean Manson informed the company in April 2026 of his intention to step down for a career break.
• · The resignation was formalized on June 23, 2026, with an effective date of June 26, 2026.
• · Manson will remain as Senior Advisor for a transition period before considering future opportunities.
• · Jeffrey Blum has been with the company since 2005 and has no family relationships or reportable transactions with the company.

25-06-2026

Curbline Properties Corp. entered into amended employment agreements with CFO Conor Fennerty and CIO John Cattonar, extending their terms through June 2029 and increasing base salaries. Fennerty's salary rises from $600,000 to $650,000 and Cattonar's from $500,000 to $550,000, with backloaded restricted stock awards of $1,500,000 and $1,370,000 respectively vesting over five years. The changes aim to retain key executives and align compensation with peers, though 70% of the stock awards remain at risk through the fourth anniversary.

• · The prior employment agreements were set to expire on September 30, 2026; new agreements extend through June 25, 2029.
• · Backloaded restricted stock awards vest over five years: 0% at year 1, 15% at year 2, 15% at year 3, 20% at year 4, 50% at year 5.
• · 70% of each backloaded award remains at risk through the fourth anniversary; 50% remains at risk until the fifth anniversary.
• · Annual time-based equity awards now have three-year ratable vesting, consistent with peer market practice.
• · Employment agreements include change in control severance protections for cash-based severance for qualifying terminations within three months prior to a change in control.
• · The Compensation Committee consulted with independent compensation consultant Gressle & McGinley.
• · Awards are granted under the Company's 2024 Equity and Incentive Compensation Plan.

25-06-2026

Keros Therapeutics appointed Anne Prener, M.D., Ph.D., to its Board of Directors effective July 1, 2026. Dr. Prener brings extensive clinical development and executive leadership experience from roles at Imbria Pharmaceuticals, Freeline Therapeutics, Gyroscope Therapeutics, Baxalta, and Novo Nordisk. The appointment is expected to support the company's pipeline advancement and long-term growth strategy.

• · Dr. Prener's appointment is effective July 1, 2026.
• · She currently serves as Senior Innovation Advisor at the University of Copenhagen and non-executive director of XSpray Pharma.
• · Previously, she was CEO of Imbria Pharmaceuticals (July 2020 – September 2024) and venture partner at SV Health Investors (September 2020 – October 2024).
• · She also served as CEO of Freeline Therapeutics (July 2017 – June 2019) and Gyroscope Therapeutics (August 2016 – July 2017).
• · Earlier roles include Global Therapeutic Area Head of Hematology and VP, Clinical Research Hematology at Baxalta, and SVP, Hemophilia R&D Portfolio at Novo Nordisk.
• · Dr. Prener holds a Ph.D. in epidemiology and an M.D. from the University of Copenhagen.
• · Keros' lead product candidate is rinvatercept for Duchenne muscular dystrophy and ALS; elritercept is for cytopenias in MDS and myelofibrosis.

25-06-2026

On June 19, 2026, the Compensation Committee of Envoy Medical, Inc. approved changes to CEO Brent Lucas's compensation, including a new base salary of $420,000 per year and a cash bonus target of $105,000 tied to strategic goals for 2026-2027. Additionally, the committee granted 1,000,000 stock options (exercisable at $0.634 per share, vesting over four years) and 1,000,000 restricted stock units (RSUs) that will vest only upon FDA approval of the company's Acclaim cochlear implant by June 18, 2030. The RSUs are contingent on a single binary regulatory event, with no guarantee of approval or timeline.

• · Stock options vest over four years with standard terms.
• · RSUs vest only upon official FDA approval notification of the Acclaim cochlear implant, with a performance period from June 19, 2026 to June 18, 2030.
• · No prior-period compensation data provided for comparison.
• · The filing does not disclose any changes to other officers or directors.

25-06-2026

AlTi Global announced the appointment of Patrick Keenan as CFO, effective July 1, 2026, succeeding Mike Harrington who is retiring. Keenan, previously Deputy CFO, has over four years at AlTi and brings expertise in financial strategy and SEC reporting. The company manages approximately $90 billion in assets with 490 professionals.

• · Patrick Keenan is a Certified Public Accountant with degrees in Accounting and Finance from Villanova University.
• · Keenan previously held senior finance roles at Aflac Global Investments, Deloitte, and Ernst & Young.
• · The transition is effective July 1, 2026, and Keenan will report to President and COO Kevin Moran.

25-06-2026

CTS Corporation announced that CEO Kieran O'Sullivan will step down as of July 6, 2026, and become Executive Chairman. Pratik Trivedi, currently COO (since December 2025), will succeed him as President and CEO. Trivedi will receive an annual base salary of $675,000 and a long-term incentive award valued at $2,150,000, while O'Sullivan will receive $625,000 as Executive Chairman with no new equity grants.

• · Trivedi initially joined CTS in April 2024 as Senior Vice President before becoming COO in December 2025.
• · The PSUs vest based on stock price performance over a three-year period (2026-2028); RSUs vest one-third per year.
• · O'Sullivan's existing equity awards will continue to vest under their original terms; no new long-term incentive award for him.
• · O'Sullivan's existing change-in-control severance agreement remains in full force and effect.
• · No family relationships or material transactions exist between Trivedi and any director or executive officer.

25-06-2026

The Coca-Cola Company announced that Jennifer Mann will step down as EVP and President of the North America Operating Unit effective August 1, 2026, with President and CFO John Murphy assuming interim leadership. Mann will remain as senior advisor through April 2027 to ensure a smooth transition. The filing highlights strong revenue and profit growth under Mann's leadership but does not provide specific financial figures or performance comparisons.

• · Jennifer Mann has been with Coca-Cola for 29 years, serving in roles including president of Global Ventures (2019-2023), SVP and chief people officer (2017-2019), and chief of staff for James Quincey (2015-2018).
• · Mann led the North America Operating Unit since January 1, 2023, and the filing states the unit delivered strong revenue and profit growth under her leadership.
• · Mann serves on multiple boards including Verizon Communications, American Beverage Association, Boys & Girls Clubs of America, Coca-Cola FEMSA, fairlife LLC, Morehouse College, and Ronald McDonald House Charities.
• · The company employs more than 700,000 people including bottling partners.

25-06-2026

IP Strategy Holdings, Inc. (IPST) held its 2026 annual meeting on June 25, 2026, where stockholders approved an amendment to the 2024 Equity Incentive Plan to increase the maximum shares issuable to 500,000 (an increase of 412,500 shares). Three Class II directors were elected, and the appointment of CBIZ CPAs P.C. as independent auditor for fiscal 2026 was ratified. However, the amendment to the equity plan received only 84,914 votes for versus 44,684 against, indicating significant shareholder opposition, and only 48% of outstanding shares were represented at the meeting.

• · The equity plan amendment passed with 84,914 votes for and 44,684 against, representing a 65.5% approval rate among votes cast (excluding broker non-votes).
• · All three director nominees were elected with over 90% of votes cast in favor.
• · Ratification of CBIZ CPAs P.C. received 251,925 votes for, 9,202 against, and 1,236 abstentions.
• · The meeting had 131,599 broker non-votes on proposals 1 and 2, indicating significant institutional holder non-voting on non-routine matters.

25-06-2026

Applied Industrial Technologies announced the resignation of director Mary Dean Hall, effective at the next annual shareholders' meeting. The departure was accepted by the Corporate Governance & Sustainability Committee on June 22, 2026. No reason for the resignation was disclosed, and no replacement has been announced.

• · Resignation effective at the next annual meeting of shareholders.
• · Resignation accepted by the Corporate Governance & Sustainability Committee.
• · No replacement director has been named as of the filing date.

25-06-2026

ACRES Commercial Realty Corp. held its 2026 Annual Meeting on June 22, 2026, where stockholders approved all proposals, including the election of nine directors, advisory say-on-pay, ratification of PricewaterhouseCoopers as auditor, issuance of ~7.49M shares for the ACC merger, and adoption of the 2026 Omnibus Equity Incentive Plan. While all proposals passed, the advisory vote on executive compensation showed notable opposition with 136,543 votes against (3.9% of votes cast), and director Murray S. Levin received the lowest support with 129,337 votes against.

• · The Merger Agreement (dated April 29, 2026) involves ACC merging with ACRES Holdings Sub LLC, with the sub continuing as a wholly-owned subsidiary.
• · Broker non-votes totaled 1,353,580 on all proposals except auditor ratification (which had no broker non-votes).
• · The auditor ratification received 4,767,097 votes for, 63,599 against, and 1,180,100 abstentions.
• · The equity incentive plan approval had 3,406,106 for, 59,552 against, and 1,191,558 abstentions.
• · The adjournment proposal was not submitted because all other proposals were approved.

25-06-2026

Amerant Bancorp Inc. announced the planned retirement of Alberto Capriles as Senior Executive Vice President and Chief Risk Officer, effective upon the appointment of his successor. Mr. Capriles will remain with the company for a transition period to assist with the handover. No successor has been named yet, and no financial impact or performance data is disclosed in this filing.

• · The retirement is effective on the appointment date of Mr. Capriles' successor, which has not yet been determined.
• · Mr. Capriles will continue employment for a transition period to assist with the Chief Risk Officer transition.

25-06-2026

On June 22, 2026, Michael Angelina notified RLI Corp. of his resignation from the Board of Directors, effective June 30, 2026. His resignation is to explore joining another insurance company's board and is not due to any disagreement with RLI. The Board acknowledged his contributions and thanked him for his service.

• · Resignation effective date: June 30, 2026
• · Filing date: June 25, 2026
• · Mr. Angelina's resignation is not due to any disagreement with the Company

25-06-2026

Boyd Gaming appointed Stacia J. Andersen and George C. Roeth to its Board of Directors. Andersen brings extensive retail and customer experience from PetSmart, Abercrombie & Fitch, and Target, while Roeth contributes leadership from Central Garden and Pet and The Clorox Company. The appointments strengthen the board's retail and consumer goods expertise, but no financial metrics or performance data were disclosed in the filing.

• · Boyd Gaming was founded in 1975 and operates 27 gaming entertainment properties in 11 states.
• · The company also manages a tribal casino in northern California and owns Boyd Interactive, a B2B and B2C online casino gaming business.
• · Boyd Rewards was recognized as the nation's favorite casino loyalty program by readers of USA Today and Newsweek.
• · Forbes named Boyd Gaming one of 'America's Best Companies'.

25-06-2026

Grand Canyon Education, Inc. (LOPE) announced the resignation of long-standing director Jack A. Henry, who served since November 2008, effective June 22, 2026. In connection, Dr. Chevy Humphrey was appointed Chair of the Audit Committee and Kevin Warren was appointed Chair of the Compensation Committee, effective June 23, 2026. The filing contains no financial figures or performance metrics.

• · Jack A. Henry joined the Board in November 2008 and served for approximately 17.6 years.
• · The resignation and committee appointments were effective within one day of each other (June 22 and June 23, 2026).
• · The filing was signed by CFO Daniel E. Bachus.
• · The filing does not disclose a reason for Mr. Henry's resignation.
• · Dr. Chevy Humphrey moves from Compensation Committee Chair to Audit Committee Chair; Kevin Warren takes over Compensation Committee Chair role.

25-06-2026

At its 2026 Annual Meeting on June 25, 2026, FinWise Bancorp shareholders elected two directors (Gerald E. Cunningham and Lisa Ann Nievaard) to serve until 2029, approved an amendment to the 2019 Stock Plan increasing authorized shares by 750,000 to 2,530,000, and ratified Baker Tilly US, LLP as independent auditor for fiscal year 2026. The vote on the stock plan increase passed with 7,097,563 shares for, but 1,938,155 shares were against, indicating notable shareholder dissent.

• · Gerald E. Cunningham received 7,747,333 votes for and 1,288,385 withheld; Lisa Ann Nievaard received 6,681,199 for and 2,354,519 withheld.
• · Proposal 2 (stock plan amendment) received 7,097,563 for, 1,938,155 against, and 0 abstentions, with 2,148,003 broker non-votes.
• · Proposal 3 (ratification of Baker Tilly) passed with 10,357,336 for, 752,192 against, and 74,193 abstentions.
• · The Annual Meeting was held to elect directors for terms until the 2029 Annual Meeting or until successors are elected.
• · The Company is an emerging growth company and has elected not to use the extended transition period for new accounting standards.

25-06-2026

Gregory T. Durant resigned from the Board of Directors of Jackson Financial Inc. on June 22, 2026, for health reasons, effective immediately. He had served as chair of the Audit Committee and a member of the Compensation Committee. Steven A. Kandarian, Board Chair, has been appointed to replace Mr. Durant as Audit Committee Chair. The resignation was not due to any disagreement with the company.

• · Mr. Durant had served on the Jackson board for the last five years.
• · The resignation was effective immediately on June 22, 2026.
• · Mr. Kandarian was previously the chair of the Board of Directors before being appointed Audit Committee Chair.

25-06-2026

eHealth, Inc. held its 2026 Annual Meeting on June 18, 2026, where stockholders approved an amendment to the 2024 Equity Incentive Plan to increase authorized shares by 1,300,000, and elected two Class II directors (Prama Bhatt and Beth A. Brooke). The meeting saw 83.19% of total voting power represented, with all four proposals passing, including ratification of Ernst & Young as auditor and advisory approval of executive compensation.

• · Proposal 1 (Director Election): Prama Bhatt received 18,471,633 votes for, 2,729,748 withheld; Beth A. Brooke received 17,453,021 for, 3,748,360 withheld; both had 8,715,413 broker non-votes.
• · Proposal 2 (Auditor Ratification): 28,357,141 for, 43,017 against, 1,516,636 abstain.
• · Proposal 3 (Advisory Say-on-Pay): 18,199,238 for, 1,375,703 against, 1,626,440 abstain, 8,715,413 broker non-votes.
• · Proposal 4 (Equity Plan Amendment): 16,122,573 for, 3,457,022 against, 1,621,786 abstain, 8,715,413 broker non-votes.
• · Record date for the Annual Meeting was April 20, 2026.

25-06-2026

Keurig Dr Pepper Inc. (KDP) announced on June 22, 2026, that Angela Stephens, SVP, Controller and Principal Accounting Officer, will retire after nearly 18 years of service. Her departure is tied to the completion of the company's previously announced separation into two independent publicly traded coffee and beverage businesses, and she will assist in establishing the controller functions for both entities before leaving.

• · The departure is effective after the completion of the previously announced separation of the coffee and beverage businesses.

25-06-2026

Kinetik Holdings Inc. announced the appointment of Craig Harris to its Board of Directors, effective June 23, 2026, adding more than 30 years of energy industry experience. Mr. Harris previously served as Senior Managing Director at Blackstone's credit business and held senior roles at several midstream firms. The appointment underscores Kinetik's focus on strengthening board expertise to advance growth and value creation in the Permian Basin.

• · Craig Harris holds a B.S. in Mechanical Engineering from Tennessee Technological University and an M.S. in Mechanical Engineering from Vanderbilt University.
• · Mr. Harris's appointment is effective June 23, 2026.
• · Kinetik is headquartered in Houston and Midland, Texas, and operates as a pure-play, Permian-to-Gulf Coast midstream C-corporation.

25-06-2026

Grindr Inc. approved a compensation increase for CFO John North, raising his base salary from $175,000 to $275,000 effective October 1, 2026, and confirmed a 100% annual target bonus. The company also modified his market-condition RSU arrangement, granting up to $19.1 million in total RSUs tied to market cap, stock price, or EBITDA thresholds through 2030, with no change to the performance targets or aggregate eligible value.

• · The modified RSU arrangement does not change the performance thresholds or the aggregate dollar value of shares Mr. North is eligible to receive if all conditions are met.
• · First performance date must occur on or before December 31, 2027; second between July 1, 2027 and March 31, 2029; third between July 1, 2027 and December 31, 2030.
• · In the event of a Change in Control, Mr. North receives fully vested RSUs for any unmet thresholds, with values of $1.6M, $7M, and $10.5M respectively, contingent on CIC price exceeding $5B, $7.5B, or $10B.
• · The Compensation Committee was assisted by independent compensation consultant Frederic W. Cook & Co., Inc.

25-06-2026

Cytek Biosciences, Inc. announced that Chief Legal Officer and Corporate Secretary Valerie Barnett will depart effective June 29, 2026, with her separation not due to any disagreement with the company's operations, policies, or practices. The filing provides no financial data or performance metrics.

• · Valerie Barnett's termination is effective June 29, 2026.
• · The departure is not due to any disagreement with the company's operations, policies, or practices.

25-06-2026

Climb Global Solutions appointed Peter Bell to its Board of Directors, effective June 25, 2026, increasing board size to five members, four of whom are independent. Mr. Bell brings over 35 years of venture capital and technology operations experience, including co-founding StorageNetworks and serving as Managing General Partner at Highland Capital Partners. The appointment strengthens the board's strategic and investment expertise as the company scales its global IT channel business.

• · Mr. Bell will serve as Chair of the Nominating and Corporate Governance Committee.
• · He currently serves as Senior Advisor at Amity Ventures and General Partner at SSC Venture Partners.
• · He co-founded StorageNetworks, a cloud computing pioneer, and led it through its IPO as CEO.
• · He holds a B.S. from Boston College, an M.B.A. from Harvard Business School, and an Honorary Doctorate from Babson College.

25-06-2026

On June 22, 2026, JFB Construction Holdings issued 25,000 shares of common stock to COO Bill Dyer as a transaction achievement bonus under the 2024 equity incentive plan, approved by unanimous board consent on June 16, 2026. The bonus is tied to the company's merger agreement with XTEND Reality Expansion Ltd. dated February 13, 2026. This is a compensatory arrangement with no revenue or earnings impact reported.

• · Board acted by unanimous written consent on June 16, 2026 to approve the bonus.
• · The bonus is tied specifically to the merger agreement with XTEND Reality Expansion Ltd. dated February 13, 2026.
• · No financial terms of the merger or the bonus value (other than share count and par value) are disclosed.

25-06-2026

Fabric.AI, Inc. (FABC) held its 2026 annual meeting on June 18, 2026, where all seven proposals were approved by stockholders. Key outcomes include the election of five directors, approval of an increased share pool for the long-term incentive plan (4,600,000 new shares, total of 5,000,000), and ratification of Stephano Slack LLC as independent auditor. The board subsequently determined future advisory votes on executive compensation will occur every three years, with the next frequency vote scheduled for 2032.

• · All director nominees received over 99% votes in favor, with Joshua Silverman receiving 766,032 votes for (4,774 withheld) and Wayne R. Walker receiving 766,312 votes for (4,494 withheld).
• · The proposal to issue shares in excess of 20% of common stock (related to Series K and J preferred stock and various warrants) passed with 749,771 votes for, 16,235 against, and 4,800 abstain.
• · Ratification of auditor Stephano Slack LLC received 769,211 votes for, 1,277 against, 318 abstain (99.8% approval).
• · The Incentive Plan Amendment passed with 746,560 votes for, 23,549 against, 697 abstain.
• · The non-binding advisory vote on executive compensation passed with 752,517 votes for, 15,779 against, 2,510 abstain.
• · The Board determined future advisory votes on executive compensation will be held every three years, with the next frequency vote set for the 2032 Annual Meeting.
• · Common stock par value is $0.0001 per share; the company is not an emerging growth company.
• · The filing was signed by CEO Joshua Silverman on June 25, 2026.
• · No broker non-votes were reported for any proposal.

25-06-2026

Spero Therapeutics, Inc. filed an 8-K on June 25, 2026, announcing a certificate of amendment to its restated certificate of incorporation, effective June 23, 2026, to increase the authorized shares of common stock from an unspecified prior amount to 240,000,000 shares and preferred stock to 10,000,000 shares. The amendment was approved by stockholders and the board, and the filing also covers director/officer changes under Items 5.02, 5.03, and 5.07, though no specific departures or elections are detailed in the exhibit.

• · The amendment was executed on June 23, 2026, and filed as an 8-K on June 25, 2026.
• · The total authorized shares of all classes increased to 250,000,000 shares (240M common + 10M preferred).
• · The amendment was adopted under Section 242 of the General Corporation Law of the State of Delaware.
• · The filing includes Items 5.02 (Director/Officer Departure/Election), 5.03 (Amendment to Articles of Incorporation), and 5.07 (Submission of Matters to a Vote of Security Holders), but the exhibit only covers the certificate of amendment.

25-06-2026

Toppoint Holdings Inc. (TOPP) announced the resignation of director Tianheng Li from the Board and all committee positions, effective June 23, 2026, for personal reasons with no disagreement with the Company. The Board subsequently appointed existing independent director Chung Ming Bruce Hui as Chair of the Compensation Committee and Chair of the Nominating and Corporate Governance Committee, effective June 25, 2026.

• · Ms. Li resigned from the Audit Committee, and as Chair of the Compensation Committee and Chair of the Nominating and Corporate Governance Committee.
• · Chung Ming Bruce Hui was appointed Chair of both the Compensation Committee and the Nominating and Corporate Governance Committee.
• · The resignation and appointment were effective immediately on their respective dates.

25-06-2026

Archrock, Inc. appointed Mohit Singh as Senior Vice President and Chief Financial Officer, effective July 6, 2026, succeeding Douglas S. Aron who retired. Singh brings over 25 years of energy industry experience, including serving as CFO of Chesapeake Energy and Expand Energy, and has held senior roles at BPX Energy, Goldman Sachs, and RBC Capital Markets.

• · Mohit Singh holds a PhD in Chemical Engineering from the University of Houston, an MBA from the University of Texas at Austin, and a BTech from IIT Kanpur.
• · Singh has served as an independent director of Powell Industries since 2024.
• · The appointment is effective July 6, 2026.

25-06-2026

Celularity Inc. appointed Steven N. Gordon as Chief Operating and Administrative Officer and as a Board member, and K. Harold Fletcher as Chief Legal and Strategy Officer and Corporate Secretary, effective June 19, 2026. Both executives had been serving as EVPs since January 2026. No compensation details or financial metrics were disclosed in this filing.

• · Steven N. Gordon has significant experience in corporate finance, operations, strategic development and capital formation in the biotechnology sector.
• · K. Harold Fletcher has substantial experience in corporate governance, securities law, strategic transactions, financings, healthcare compliance and public company matters.
• · No family relationships exist between either new officer and any director or executive officer.
• · No arrangements or understandings exist between either officer and any other person regarding their appointments, other than with the Company.

25-06-2026

Reliance Global Group announced the appointments of Zack Wilder (CTO, from Coinbase and Capital One), Judah Korman (COO), and Mordy Beyman (EVP) to lead a dual strategy: building AI-native insurance products and powering its agency acquisition roll-up with an AI backbone. The company aims to differentiate itself from traditional insurers and pure-play insurtech firms by embedding AI into both its operational platform and insurance product development.

• · No specific revenues, growth rates, acquisition pipeline, or prior performance metrics were disclosed in the press release.
• · The company is relying on forward-looking statements regarding AI integration and product development; no concrete timelines or financial targets were provided.

25-06-2026

NextCure, Inc. held its 2026 Annual Meeting on June 18, 2026, where stockholders approved an amendment and restatement of the 2019 Omnibus Incentive Plan, increasing authorized shares by 80,000, and elected two Class I directors. While the advisory vote on executive compensation passed overwhelmingly (99.6% for), the incentive plan amendment received only 64.8% support, with 35.2% voting against, indicating notable shareholder dissent.

• · The A&R 2019 Plan includes an amended evergreen provision where the annual increase will be based on the Company’s outstanding shares on a fully diluted basis (including outstanding prefunded warrants).
• · Proposal 2 (ratification of auditor) passed with 98.5% support (2,774,832 for, 32,329 against, 8,813 abstain).
• · Proposal 1: Anne Borgman received 75.3% of votes cast (1,595,507 for vs 522,009 against); John G. Houston received 92.6% of votes cast (1,961,916 for vs 155,737 against).
• · The filing date is June 25, 2026, with the event date of June 18, 2026.

25-06-2026

JPMorgan Chase & Co. announced in a June 25, 2026 press release (filed as an 8-K) a change in its board of directors or senior officers. The filing does not disclose specific financial figures or performance metrics, only the departure or election of a director/officer.

• · The filing is an 8-K under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers).
• · No financial data, performance metrics, or forward-looking guidance is included in the filing.

25-06-2026

Planet Fitness appointed Sudhanshu Priyadarshi as CFO and President, International, effective immediately. He brings over 25 years of experience from Keurig Dr Pepper, PepsiCo, and other global firms. Interim CFO Tom Fitzgerald will remain as an advisor through mid-September 2026 to ensure a smooth transition.

• · Mr. Priyadarshi previously served as CFO and President, International of Keurig Dr Pepper, co-leading enterprise-wide strategic plan.
• · At Vista Outdoor, he helped close nine acquisitions and drive a 6X increase in EBITDA.
• · He holds an MBA from the University of Technology in Sydney, Australia.
• · Planet Fitness had approximately 21.5 million members and 2,909 clubs as of March 31, 2026.
• · Approximately 90% of Planet Fitness clubs are owned and operated by independent business owners.

25-06-2026

SELLAS Life Sciences Group, Inc. entered into amended employment and severance agreements with its CEO, CFO, and Chief Development Officer on June 24, 2026. The CEO's change-in-control severance will now be paid in a lump sum, while the CFO and CDO received updated severance terms with nine-month non-change-of-control benefits and enhanced 15-month change-of-control benefits including full equity vesting. The changes were approved by the Board following a compensation consultant review.

• · The Stergiou Amendment changes only the payment method of change-in-control severance to a lump sum; all other terms unchanged.
• · Burns and Cicic agreements provide nine months of base salary and pro-rata target bonus for non-change-of-control termination, plus COBRA for nine months.
• · Change-of-control severance for Burns and Cicic includes 15 months base salary lump sum, target bonus lump sum, 18 months COBRA, and full equity vesting.
• · Severance is contingent on signing a separation and general release agreement.

25-06-2026

CoStar Group stockholders overwhelmingly reelected all director nominees with support ranging from 93.92% to 99.50% and approved the advisory say-on-pay proposal with 71.38% of votes cast at the June 23, 2026 Annual Meeting. The company highlighted that its Board unanimously approved a plan to deliver revenue growth and prioritize EBITDA margin expansion, and management engaged with over 500 stockholders to communicate strategic priorities. However, the say-on-pay vote, while passing, received only 71.38% support, which is below the typical 90%+ threshold seen for many large-cap companies, indicating that a notable minority of stockholders (over 28%) did not support the redesigned executive compensation program.

• · The director with the lowest support was Louise S. Sams at 93.92%.
• · Robert W. Musslewhite received 94.76% support, also slightly below the 95% threshold often used as a benchmark for strong director support.
• · The say-on-pay vote of 71.38% is significantly lower than the director votes, indicating shareholder dissent on executive compensation despite the redesigned program.
• · CoStar Group's Board added three new directors earlier in the year.
• · The company's websites attracted 131 million average monthly unique visitors in Q1 2026.
• · The Board and Compensation Committee engaged with the Top 50 stockholders representing 77% of outstanding shares.
• · CoStar Group is an S&P 500 company founded in 1986.

25-06-2026

AeroVironment appointed William J. Lynn III to its Board of Directors, effective June 24, 2026. Lynn brings extensive experience from his roles as Chairman and CEO of Leonardo DRS, former U.S. Deputy Secretary of Defense, and senior positions at Raytheon and the Department of Defense. The appointment is expected to provide valuable insights in national security and defense technology as the company scales its leadership in the global security environment.

• · William J. Lynn III served as Chairman and CEO of Leonardo DRS from 2012 until 2026.
• · He served as the 30th U.S. Deputy Secretary of Defense from 2009 to 2011 under Secretaries Robert Gates and Leon Panetta.
• · Lynn led the development of the Department of Defense's first cyber strategy.
• · He previously held senior roles at Raytheon Company and as Under Secretary of Defense (Comptroller) and CFO.
• · Lynn holds a J.D. from Cornell Law School and an M.P.A. in international affairs from Princeton University.
• · AeroVironment develops autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber/electronic warfare capabilities.

25-06-2026

SolarEdge Technologies disclosed that former CFO Asaf Alperovitz stepped down effective May 31, 2026, and remained in a transitional capacity through June 9, 2026. On June 22, 2026, the Compensation Committee approved a special cash bonus of NIS 279,000 (approximately two months' base salary) to Mr. Alperovitz in recognition of his performance during the transition. The filing does not include any financial results or period-over-period comparisons.

• · Mr. Alperovitz notified the company of his decision to step down as CFO in a prior 8-K filed March 10, 2026.
• · He ceased serving as CFO effective May 31, 2026, and remained in a transitional capacity through June 9, 2026.
• · The special bonus of NIS 279,000 represents two months of his base salary.

25-06-2026

Laser Photonics Corp (LASE) announced the departure of Roman Franklin as Principal Financial Officer via a termination agreement with The CFO Portal, LLC, and appointed Ralph Venegas as Principal Financial Officer and Acting CFO. Venegas, currently VP of Finance & Reporting at Fonon Quantum Technologies, Inc., brings extensive accounting and audit experience. The company paid Franklin $50,000 as part of the termination agreement.

• · The Termination Agreement was entered into on June 24, 2026.
• · The initial MSA with CFO Portal was dated May 7, 2026, for a six-month term.
• · Ralph Venegas joined FQTI on February 18, 2026.
• · Venegas previously served as Financial Controller and Acting CFO of Summit Aerospace, Inc. since March 2024.
• · Venegas holds an AB in Accounting from Universidad La Salle and a Master of Accounting from Nova Southeastern University.

25-06-2026

AEN Group Ltd. announced the resignation of Ms. Dandan Chen as Director and CEO, effective June 25, 2026, with no disagreement cited. The Board elected Liao Xiu Ze as CEO, adding to his existing roles as CFO, Treasurer, and Secretary, concentrating significant authority in one individual.

• · Ms. Chen's resignation was not due to any disagreement with the company's operations, policies, or practices.
• · Liao Xiu Ze now holds four officer positions: CEO, CFO, Treasurer, and Secretary.
• · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.

25-06-2026

Lion Copper & Gold Corp. appointed Ms. Maria Milagros ('Millie') Paredes as CFO and Corporate Secretary, effective June 22, 2026, succeeding Ms. Lei Wang who will remain as an advisor. Ms. Paredes brings over 30 years of international mining and finance experience, including prior CFO roles at Mako Mining Corp. and Bellhaven Copper & Gold, as well as senior roles at Rio Tinto, Intel, and Hewlett-Packard. The company is advancing its Yerington Copper Project through an earn-in agreement with Nuton LLC, a Rio Tinto venture.

• · Ms. Paredes holds an MBA from Cornell University, an MS in Economic Geology from Iowa State University, and a BS in Geological Engineering from Universidad Nacional de Ingeniería in Peru.
• · She is fluent in English and Spanish.
• · Lei Wang will stay with the company as an advisor.